Skip to main content
. 2018 Mar 16;34(5):1100–1106. doi: 10.3904/kjim.2017.226

Figure 1.

Figure 1.

Flow diagram of patient inclusion in this study. NA, not available; ER, estrogen receptor; HER2, human epidermal growth factor receptor 2. a Follow-up loss, double primary cancer, male.